Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MÖLNLYCKE HEALTH CARE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1% 1.1%   Bankruptcy risk   2.7% 14.7% 14.5% 14.5% 2.1% 3.1% 8.1% 8.1%   Credit score (0-100)   62 14 13 14 67 57 30 30   Credit rating   BBB BB BB BB A BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   24,671 0.0 0.0 0.0 42,087 57,974 0.0 0.0   EBITDA   8,446 0.0 0.0 0.0 12,707 21,782 0.0 0.0   EBIT   8,326 0.0 0.0 0.0 12,581 21,626 0.0 0.0   Pre-tax profit (PTP)   8,324.0 0.0 0.0 0.0 12,991.0 22,613.0 0.0 0.0   Net earnings   6,414.0 0.0 0.0 0.0 10,114.0 17,606.0 0.0 0.0   Pre-tax profit without non-rec. items   8,324 0.0 0.0 0.0 12,991 22,613 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   334 0.0 0.0 0.0 308 250 0.0 0.0   Shareholders equity total   7,724 0.0 0.0 0.0 18,133 25,739 8,239 8,239   Interest-bearing liabilities   15,830 0.0 0.0 0.0 6,332 2,765 0.0 0.0   Balance sheet total (assets)   33,304 0.0 0.0 0.0 35,578 40,283 8,239 8,239   Net Debt   15,830 0.0 0.0 0.0 787 -4,324 -8,239 -8,239     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   24,671 0.0 0.0 0.0 42,087 57,974 0.0 0.0   Gross profit growth   -24.4% -100.0% 0.0% 0.0% 0.0% 37.7% -100.0% 0.0%   Employees   19 0 0 0 30 33 0 0   Employee growth %   -5.0% -100.0% 0.0% 0.0% 0.0% 10.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   33,304 0 0 0 35,578 40,283 8,239 8,239   Balance sheet change%   0.4% -100.0% 0.0% 0.0% 0.0% 13.2% -79.5% 0.0%   Added value   8,446.0 0.0 0.0 0.0 12,581.0 21,782.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -20 -334 0 0 182 -214 -250 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   4.0 0.0 0.0 0.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   33.7% 0.0% 0.0% 0.0% 29.9% 37.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   25.1% 0.0% 0.0% 0.0% 36.6% 59.7% 0.0% 0.0%   ROI %   37.2% 0.0% 0.0% 0.0% 53.3% 85.4% 0.0% 0.0%   ROE %   72.0% 0.0% 0.0% 0.0% 55.8% 80.3% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   23.2% 0.0% 0.0% 0.0% 51.0% 63.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   187.4% 0.0% 0.0% 0.0% 6.2% -19.9% 0.0% 0.0%   Gearing %   204.9% 0.0% 0.0% 0.0% 34.9% 10.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.1% 0.0% 0.0% 0.0% 1.5% 0.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.3 0.0 0.0 0.0 2.0 2.8 0.0 0.0   Current Ratio   1.3 0.0 0.0 0.0 2.0 2.8 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 5,545.0 7,089.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   7,861.0 0.0 0.0 0.0 17,825.0 25,489.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   445 0 0 0 419 660 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   445 0 0 0 424 660 0 0   EBIT / employee   438 0 0 0 419 655 0 0   Net earnings / employee   338 0 0 0 337 534 0 0